Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Robert Peter Gale

View this query on the Wikidata Query Service
Final Warning : The Legacy of Chernobyl

Radiation

Blood basophil concentration at diagnosis, not percentage, correlates with therapy-related outcomes in newly-diagnosed chronic phase chronic myeloid leukaemia

Correction: Factors Affecting the Receptiveness of Chinese Internists and Surgeons Toward Artificial Intelligence–Driven Drug Prescription: Protocol for a Systematic Survey Study (Preprint)

Data from Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia

Data from Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia

European LeukemiaNet criteria for safety and efficacy evaluation of new drugs for myelofibrosis.

Factors Affecting the Receptiveness of Chinese Internists and Surgeons Toward Artificial Intelligence–Driven Drug Prescription: Protocol for a Systematic Survey Study (Preprint)

Figure S1 from Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia

Figure S2 from Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia

Figure S3 from Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia

Figure S3 from Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia

Figure S3 from Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia

Figure S4 from Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia

Figure S4 from Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia

Figure S5 from Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia

Figure S6 from Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia

Supplementary Tables S1-S5 from Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia

Paulina is supported by:

About Paulina

Help